Author

Curtis A. Engelhart

Cornell UniversityORCID 0000-0002-9324-5861Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2

Frequent Co-Authors

Dirk SchnappingeriD· 2 shared Laura A. T. CleghorniD· 2 shared Alasdair Smith· 1 shared Alice DawsoniD· 1 shared Beatriz BaragañaiD· 1 shared Chimed Jansen· 1 shared Eva María López-Román· 1 shared Fábio K. TamakiiD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

Dirk SchnappingerORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

MicrobiologyJournal of Medicinal ChemistryPeer-reviewedAug 1, 2025

Design and development of lysyl tRNA synthetase inhibitors, for the treatment of tuberculosis

Susan H. Davis, Michael Mathieson, Kirsteen I. Buchanan…·Laura A. T. Cleghorn

The paper describes the development of lysyl tRNA synthetase inhibitors for tuberculosis treatment, optimizing compounds for preclinical and potential clinical use.

3 citations

experimental assaydrug response / drug discovery

𝕏 PostBluesky

MicrobiologybioRxivPreprintMar 31, 2025

Common biological features of Mycobacterium tuberculosis MmpL3 inhibitors

Lauren Ames, R. H. Allen, Helena I. Boshoff…·Tanya Parish

This study identifies common biological features of MmpL3 inhibitors, showing potent activity against M. tuberculosis and highlighting their potential as drug candidates.

1 citation

experimental assaydrug response / drug discovery

𝕏 PostBluesky